The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras
Official Title: Multicentered Observational Prospective Cohort Study on the Treatment of Metastatic Colorectal Cancer and the Role of Evaluating K-Ras
Study ID: NCT01651013
Brief Summary: The purpose of this study is to describe the treatments received and outcomes of patients with metastatic colorectal cancer, what percentage of these patients have K-Ras mutation of the tumor, and to describe the costs of treatments. Information will also be collected regarding risk factors, variables among treatment centers and patients, and explorative analyses will be done to try to identify factors that impact prognosis and factors that predict tolerability and response to treatment.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
A.O.G. Rummo, Benevento, , Italy
Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento Entero-proctologico, Napoli, , Italy
Ospedale Civile Umberto I, Nocera Inferiore, , Italy
C:R.O. Regione Basilicata Ospedale Giustino Fortunato, Rionero in Vulture, , Italy
Name: R. V. Iaffaioli, M.D.
Affiliation: National Cancer Institute, Naples
Role: PRINCIPAL_INVESTIGATOR
Name: G. Nasti, M.D.
Affiliation: National Cancer Institute, Naples
Role: PRINCIPAL_INVESTIGATOR
Name: M. C. Piccirillo, M.D.
Affiliation: National Cancer Institute, Naples
Role: PRINCIPAL_INVESTIGATOR